Integra Lifesciences Holdings (IART) Revenue (2009 - 2026)

Integra Lifesciences Holdings' Revenue history runs 18 years deep, the most recent figure standing at $391.9 million for Q1 2026.

• In Q1 2026, Revenue rose 2.42% year-over-year to $391.9 million; the TTM figure through Mar 2026 stood at $1.6 billion (up 1.24% YoY), while the FY2025 annual figure was $1.6 billion, up 1.53% from the prior year.
• Revenue came in at $391.9 million for Q1 2026 at Integra Lifesciences Holdings, down from $434.9 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $442.6 million in Q4 2024 to a low of $368.9 million in Q1 2024.
• A 5-year average of $396.3 million and a median of $391.9 million in 2026 frame the typical range for Revenue.
• Across the five-year window, Revenue dropped 4.16% in 2023 and climbed 11.49% in 2024, its largest moves.
• Integra Lifesciences Holdings' Revenue stood at $398.0 million in 2022, then fell by 0.25% to $397.0 million in 2023, then gained by 11.49% to $442.6 million in 2024, then declined by 1.74% to $434.9 million in 2025, then decreased by 9.89% to $391.9 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $391.9 million, $434.9 million, and $402.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison